Stryker | SYK - Ebitda

Aktienkurs
339.15
Täglich Wechseln
0.01 0.003%
Monatlich
-1.92%
Jährlich
-3.18%
Q2 Prognose
329.89




Ebitda Veränderung Datum
Abbott USD 3.09B 44M 2025-09
AtriCure USD 19.86M 2.06M 2025-12
Avanos Medical USD 10M 73.9M 2025-09
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.37B 1000K 2025-09
CONMED USD 80.36M 49.87M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Danaher USD 2.13B 252M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 464.3M 4.7M 2025-09
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 115.53M 9.22M 2025-09
Hologic USD 330.4M 16.6M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 919.7M 21M 2025-09
J&J USD 9.52B 389M 2025-09
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Olympus JPY 45.72B 4.58B 2025-12
Smith & Nephew USD 796M 139M 2025-12
Steris USD 389.7M 22.5M 2025-09
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Terumo JPY 69.99B 3.22B 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12